GlobeNewswire Inc | Mar 4, 2021 12:18PM EST

March 04, 2021

Filing of the 2020 U.S. Form 20-F and French Document dEnregistrement Universel containing the Annual Financial Report

PARIS, France March 4, 2021 - Sanofi announces today the filing of its Form 20-F with the U.S. Securities and Exchange Commission (SEC) and its Document dEnregistrement Universel containing its Annual Financial Report with the French market regulator Autorit des marchs financiers (AMF).

These documents are available on the companys website: https://www.sanofi.com/en/investors/reports-and-publications/financial-and-csr-reports.

In addition, the Form 20-F is available on the website of the SEC (www.sec.gov) and the Document dEnregistrement Universel is available on the website of the AMF (www.amf-france.org). A hard copy of these documents, each of which contains our complete audited financial statements, may be received free of charge, upon request.



About Sanofi

Sanofi is dedicated to supporting people through their health challenges. Weare a global biopharmaceutical company focused on human health. We preventillness with vaccines, provide innovative treatments to fight pain and easesuffering. We stand by the few who suffer from rare diseases and the millionswith long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transformingscientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life



Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Yvonne NaughtonMedia Relations ContactAshleigh Koss Tel: +1 (908) 981-8745Ashleigh.Koss@sanofi.com Investor Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne GrecoSandrine GuendoulTel.: +33 (0)1 53 77 46 46 mr@sanofi.com IR main line: Tel.: +33 (0)1 53 77 45 45 investor.relations@sanofi.com



https://www.sanofi.com/en/investors/contact



Attachment

-- PDF